Activity hots up on aligning EMA and HTA decisions
This article was originally published in SRA
Executive Summary
Momentum is building around efforts to identify how the European Medicines Agency and EU health technology assessment (HTA) bodies can become better aligned so as to improve how drug sponsors fare in HTAs.